Lai‐ping Zhong

2.9k total citations
96 papers, 1.7k citations indexed

About

Lai‐ping Zhong is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Lai‐ping Zhong has authored 96 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Surgery, 29 papers in Molecular Biology and 28 papers in Oncology. Recurrent topics in Lai‐ping Zhong's work include Head and Neck Cancer Studies (27 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Oral Health Pathology and Treatment (8 papers). Lai‐ping Zhong is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Salivary Gland Tumors Diagnosis and Treatment (15 papers) and Oral Health Pathology and Treatment (8 papers). Lai‐ping Zhong collaborates with scholars based in China, United States and Singapore. Lai‐ping Zhong's co-authors include Zhiyuan Zhang, Chenping Zhang, Wantao Chen, Ying Liu, Guan-Fu Chen, Chenping Zhang, Dongwang Zhu, Zhiyuan Zhang, Wu‐tong Ju and Hongya Pan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Lai‐ping Zhong

93 papers receiving 1.7k citations

Peers

Lai‐ping Zhong

ONCOL

SURGE

OTORH

Shuichi Kawashiri Japan

Shui‐Hong Zhou China

Coro Bescós Spain

Tetsuya Tamatani Japan

Yong‐Kie Wong Taiwan

Karin Oien United Kingdom

Walter King United States

Bin Jiang China

Susumu Nakahara Japan

Julie Izzo United States

Shuichi Kawashiri Japan

Lai‐ping Zhong

738 ×1.1

533 ×1.2

ONCOL

193 ×0.5

SURGE

478 ×1.6

145 ×0.5

OTORH

Citations per year, relative to Lai‐ping Zhong Lai‐ping Zhong (= 1×) peers Shuichi Kawashiri

Countries citing papers authored by Lai‐ping Zhong

Since Specialization

Citations

This map shows the geographic impact of Lai‐ping Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lai‐ping Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lai‐ping Zhong more than expected).

Fields of papers citing papers by Lai‐ping Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lai‐ping Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lai‐ping Zhong. The network helps show where Lai‐ping Zhong may publish in the future.

Co-authorship network of co-authors of Lai‐ping Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Lai‐ping Zhong. A scholar is included among the top collaborators of Lai‐ping Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lai‐ping Zhong. Lai‐ping Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Xinxin, Qi Zhu, Zhen Cai, et al.. (2025). Luvometinib in patients with Langerhans cell histiocytosis, Erdheim–Chester disease, and other histiocytic neoplasms: a single-arm, multicentre, phase 2 study. EClinicalMedicine. 88. 103486–103486. 1 indexed citations

Dou, Ning, et al.. (2025). mPEG@ELA-11 Alleviates Atherosclerosis via AKT-ER Stress-Mediated Macrophage Modulation. PubMed. 6. 203–203.

Liu, Ying, Limin Liu, Wen Jiang, et al.. (2024). Nomogram to Predict Nodal Recurrence‐Free Survival in Early Oral Squamous Cell Carcinoma. Oral Diseases. 31(3). 718–728.

Zhong, Lai‐ping, Zhihang Zhou, Yi Lu, et al.. (2024). Associations of ctDNA clearance and pathological response after neoadjuvant treatment in patients with locally advanced oral cancer.. Journal of Clinical Oncology. 42(16_suppl). 6043–6043. 1 indexed citations

Ju, Wu‐tong, Ying Liu, Jingjing Sun, et al.. (2023). Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study. International Journal of Surgery. 109(4). 879–886. 2 indexed citations

Dou, Shengjin, Lin Zhang, Rongrong Li, et al.. (2023). Adjuvant PD-1 antibody in recurrent, previously irradiated oral cavity cancer treated with salvage surgery. Clinical and Translational Radiation Oncology. 40. 100623–100623. 1 indexed citations

Ju, Wu‐tong, Ronghui Xia, Dongwang Zhu, et al.. (2022). A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma. Nature Communications. 13(1). 78 indexed citations

Sun, Wenwen, Tongchao Zhao, Timothy Aladelusi, et al.. (2021). Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 50(8). 795–802. 3 indexed citations

Liang, Siyuan, Tongchao Zhao, Zhihang Zhou, et al.. (2021). Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo. Translational Oncology. 14(6). 101074–101074. 18 indexed citations

10.

Xu, Hongyuan, Dongwang Zhu, Lai‐ping Zhong, et al.. (2019). Effects of insulin-like growth factor binding protein 3 on cell growth and tumorigenesis in oral squamous cell carcinoma. Translational Cancer Research. 8(5). 1709–1717. 1 indexed citations

11.

Zhao, Tongchao, Siyuan Liang, Wu‐tong Ju, et al.. (2019). Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma. Clinical Nutrition. 39(9). 2751–2758. 8 indexed citations

12.

Yang, Cuixia, Jun Ma, Dongwang Zhu, et al.. (2014). GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma. Annals of Oncology. 25(6). 1215–1222. 52 indexed citations

13.

Zhu, Dongwang, Xiao Yang, Chengzhe Yang, et al.. (2013). Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade. Oral Oncology. 49(6). 542–550. 15 indexed citations

14.

Zhong, Lai‐ping, et al.. (2011). Surgical management of solitary venous malformation in the midcheek region. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 114(2). 160–166. 11 indexed citations

15.

Yang, Xi, Guoxin Ren, Chenping Zhang, et al.. (2010). Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma. BMC Cancer. 10(1). 623–623. 21 indexed citations

16.

Zhong, Lai‐ping, et al.. (2010). Overexpression of Galectin-1 is negatively correlated with pathologic differentiation grade in oral squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 136(10). 1527–1535. 17 indexed citations

17.

Ye, Dongxia, Xiaojian Zhou, Hongya Pan, et al.. (2010). Establishment and characterization of an HPV16 E6/E7-expressing oral squamous cell carcinoma cell line with enhanced tumorigenicity. Medical Oncology. 28(4). 1331–1337. 8 indexed citations

18.

Zhang, Lei, Hongya Pan, Lai‐ping Zhong, et al.. (2010). Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis. Journal of Oral Pathology and Medicine. 39(6). 470–476. 17 indexed citations

19.

He, Di, Qin Xu, Ming Yan, et al.. (2009). The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer. 9(1). 343–343. 64 indexed citations

20.

Chen, Guan-Fu & Lai‐ping Zhong. (2003). A bilateral musculomucosal buccal flap method for cleft palate surgery. Journal of Oral and Maxillofacial Surgery. 61(12). 1399–1404. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact